2. Introduction
ā¢ MI or Heart attack are terms used anonymously,
but the preferred term is MI.
ā¢ In an MI an area of the myocardium is
permanently destroyed.
ā¢ MI is usually caused by reduced or decreased
blood flow in a coronary artery due to rupture of
an atherosclerotic plaque and subsequent
occlusion of the artery by a thromus.
3. Etiopathophysilogy
ā¢ MI refers to the processes by which myocardial tissue is
destroyed in regions of the heart that are deprived of an
adequate blood supply because of reduced coronary artery
blood flow.
ā¢ Eighty percent to 90% of all acute MI are secondary to
thrombus formation.
ā¢ When thrombus develops , perfusion to the myocardium
distal to the occlusion is halted,resulting in necrosis.
4. Continue
ā¢ The acute MI process takes time. Cardiac cells can
withstand in ischaemic conditions for approximately
20 minutes before cellular death begins.
ā¢ The earliest tissue to become ischemic is the sub
endocardium (the innermost layer of tissue in the
cardiac muscle)
ā¢ If ischemia persists,it takes approximately 4 to 6
hours for the entire thickness if the heart muscle to
become necrosed.
6. Continue....
ā¢ Infractions are usually described based on
location if damage ( anterior,inferior,posterior,or
lateral wall).
ā¢ Descriptions are used to further identify an
MI:the type of MI ( ST- segment elevation
myocardial infraction STEMI and non-segment-
elevation myocardial infraction NSTEMI
7. Clinical manifestations of MI
1) CARDIOVASCULAR
ā¢ Chest pain : chest pain occurs suddenly,severe immobilizing chest pain
that not relieved by rest ,position change,and medications.
ā¢ Increased jugular venous distention
ā¢ BP may be elevated because of sympathetic stimulation or decreased BP
because of decreased contractility, development if cariogenic shock
ā¢ Decrease pulse rate
ā¢ ST- segment and T-wave changes, ECG may show tachycardia,
bradycardia, or dysrhythmias.
8. Respiratory
ā¢ Shortness of breath (SOB)
ā¢ Dyspnea, tachypnea, and crackles if MI has
caused pulmonary congestion.
ā¢ Pulmonary edema
14. Complications
ā¢ Dysrhythmias ( the most common complications
after an MI in 80% of MI cases.
ā¢ Acute pulmonary edema
ā¢ Heart failure
ā¢ Cariogenic shock
ā¢ Papillary muscle dysfunction
ā¢ Pericarditis and cardiac tamponade
15. Assessment and diagnostic findings
ā¢ The diagnosis of MI is generally based on the
presenting symptoms, the ECG, and laboratory
test results (e.g serial cardiac biomarke valve)
16. Patient history
ā¢ The patient history has two parts: the
description of the presenting symptoms and
the history of previous illness and family
history of the cardiovascular disease.
18. ā¢ The ECG provides information that assists in
diagnosing acute MI.
ā¢ It should be obtained within 10 minutes
from the patient a reports chest pain
20. Laboratory tests
ā¢ Laboratory tests called āCARDIAC BIOMARKERSā
are used to diagnose AMI.
ā¢ Creatine kinase āMB or CK-MB
ā¢ myoglobin
ā¢ Troponin T or I
21. Medical management
ā¢ The goal of medical management is to
1. Minmize myocardial damage
2. Preserve myocardial function and prevent
complications
*Minimizing myocardial damage is also
reducing myocardial oxygen demand and
increasing oxygen supply.
23. Thrombolytics
ā¢ Thrombolytics are usually administered IV,
although some may also be given directly into the
coronary artery in cardiac catheterization.
ā¢ The purpose of thrombolytics is to dissolve and
lyse thrombus in a coronary artery allowing blood
to flow through the coronary artery again
(reperfusion), minimising the size of the
infraction and preserving ventricular function.
24. Conti...
ā¢ Thrombolytics should not be used if the patient
is bleeding or has a bleeding disorders.
ā¢ To be effective,thrombolytics must be
administered as early as possible after the onset
of symptoms that indicate an acute MI, generally
within 3 to 6 hours.
25. Contraindications of thrombolytic therapy
ā¢ Previous hemorrhagic stroke
ā¢ Known intracranial tumour
ā¢ Active internal bleeding
ā¢ Severe uncontrolled hypertension
ā¢ Recent head injury
ā¢ current use of anticoagulants
26. Analgesics
ā¢ Morphine sulfate administered in IV boules to
reduce pain and anxiety
ā¢ The cardiovascular response to morphine is
monitored carefully particularly BP and
respiratory rate.
29. Cardiac rehabilitation
ā¢ Cardiac rehabilitation is a comprehensive
long term program that involves periodic
evaluation,prescribed exercise and
education and counseling about cardiac risk
factors modification.
31. Aras of cardiac rehabilitation
ā¢ Smoking cessation
ā¢ Lipid management
ā¢ Weight control
ā¢ BP control
ā¢ Improve exercise tolerance
ā¢ Symptoms control
ā¢ Psychological well-being /strss management
32. Nursing management for a patient with acute
MI
ā¢ Achieving a balance between myocardial oxygen supply
and demand
ā¢ This are achieved via oxygen administration and
medication (Nitroglycerin)
ā¢ Prevention of complications
ā¢ Continuous monitoring of cardiac functions
ā¢ Continuous ECG monitoring
ā¢ Hemodynamic monitoring
ā¢ Monitor and record intake and urine output
33. Conti.
ā¢ Closely monitor and prevent complications
associated with MI particularly dysrhythmia and
cardiigenic shock
ā¢ Provide emotional and psychological support
ā¢ Explain and provide adequate information and
knowledge about disease cond and treatment
process
34. Risk factors modification
ā¢ Daily fat intake less than 309 % of total calories
ā¢ Maintenance of serum cholesterol level
ā¢ Maintain LDL levels less than 70 mg/dl
ā¢ Stop smoking and reduce daily salt intake
ā¢ Control Hypertension and diabetes
ā¢ Increase physical activity and reduce weight
35. Nursing diagnosis
ā¢ Ineffective cardiac tissue perfusion related to
reduced coronary blood flow from coronary
thrombus and atherosclerotic plaque
ā¢ Risk for imbalnved fluid
ā¢ Death of anxiety
ā¢ Deficient knowledge about post-MI and self care